Related by context. Frequent words. (Click for all words.) 58 confirmatory Phase III 56 deforolimus 56 registrational 55 ATL# [001] 55 phase IIa 54 phase IIb 54 Phase 1a 54 Genasense R oblimersen 54 TASQ 53 methylnaltrexone 53 BLA submission 53 custirsen 53 Zelrix 52 Plenaxis R 52 elotuzumab 52 alvimopan 52 Phase II 52 MIRCERA 52 Azedra 52 drug conjugate 52 Phase Ib clinical 52 Phase III 52 Phase III Clinical Trial 52 Pivotal Trial 51 Icatibant 51 outlicensing 51 ofatumumab 51 Neuradiab 51 multicentre 51 prospective multicenter 51 randomized Phase III 51 AnGes 51 placebo controlled clinical 51 MOZOBIL 51 Phase 1b clinical 51 Amrubicin 51 QNEXA 51 tanespimycin 51 StemEx 51 multicenter clinical 51 FOLOTYN 50 Pivotal Phase III 50 ridaforolimus 50 RSD# 50 Scientific Advice 50 Telavancin 50 TOCOSOL Paclitaxel 50 Neo Urinary Conduit 50 Pirfenidone 50 Phase Ib 50 Amigal 50 CCX# 50 vernakalant oral 50 oral calcitonin 50 teduglutide 50 Anthim 50 LightTouch 50 Nippon Kayaku 50 CoFactor 50 Phase III clinical 49 PA# [002] 49 REPLAGAL 49 dalbavancin 49 Veronate 49 omecamtiv mecarbil 49 Mutual Recognition Procedure 49 IoGen 49 Allovectin 7 R 49 GV# [001] 49 confirmatory Phase 3 49 Phase IIa clinical 49 NEUMUNE 49 Phase 2b 49 Phase IIa 49 eniluracil 49 apaziquone 49 TORISEL 49 KRN# 49 TELCYTA 49 Panzem R 49 Traficet EN 49 Phase IIb clinical 49 OLEPTRO TM 48 double blinded placebo 48 preclinical toxicology 48 Phase III Trial 48 Marketing Authorization Application MAA 48 QbD 48 Virulizin R 48 Phase III pivotal 48 Investigational Device Exemption 48 BrachySil 48 Diamyd ® 48 Rhucin ® 48 PRECiSE 48 BCX# 48 KNS # 48 romidepsin 48 ATryn ® 48 supplemental Biologics License Application 48 Marketing Authorization Application